ACT-281959
ACT-281959 is an orally active prodrug of Selatogrel , a P2Y12 receptor antagonist. ACT-281959 can inhibit platelet aggregation and can be used for the research of cardiovascular disease[1].
Product Specifications
CAS Number
1159501-31-1
UNSPSC
12352005
Target
P2Y Receptor
Related Pathways
GPCR/G Protein
Field of Research
Cardiovascular Disease
Smiles
O=C(N1CCN(C([C@@H](NC(C2=NC(C3=CC=CC=C3)=NC(N4C[C@@H](OC)CC4)=C2)=O)CP(OCOC(OC(C)C)=O)(OCOC(OC(C)C)=O)=O)=O)CC1)OCCCC
Molecular Formula
C38H55N6O14P
Molecular Weight
850.85
References & Citations
[1]Caroff E, et al. 4- ((R) -2-{[6- ((S) -3-Methoxypyrrolidin-1-yl) -2-phenylpyrimidine-4-carbonyl]amino}-3-phosphonopropionyl) piperazine-1-carboxylic Acid Butyl Ester (ACT-246475) and Its Prodrug (ACT-281959), a Novel P2Y12 Receptor Antagonist with a Wider Therapeutic Window in the Rat Than Clopidogrel. J Med Chem. 2015 Dec 10;58 (23) :9133-53.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
P2Y12 Receptor
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog